Related references
Note: Only part of the references are listed.Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Laxmikant Gadhe et al.
BIOPHYSICAL CHEMISTRY (2022)
Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
Ichiro Kawahata et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
David Finkelstein et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies
Leah J. Weston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons
Ichiro Kawahata et al.
BIOMEDICINES (2021)
Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
Sara Elfarrash et al.
PLOS ONE (2021)
Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2
Kazunori Sano et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129
Leah J. Weston et al.
NEUROBIOLOGY OF DISEASE (2021)
T-Type Ca2+ Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
Jing Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3
Naoya Fukui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
Chun-Wei Chang et al.
FRONTIERS IN NEUROLOGY (2020)
Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia
Ichiro Kawahata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease
Weiwei Wu et al.
PLOS ONE (2020)
Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
Eva Schaeffer et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Plasma alpha-synuclein detected by single molecule array is increased in PD
Adeline S. L. Ng et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
Xinhe Wang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis
Junpei Kobayashi et al.
FASEB JOURNAL (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Brain-First versus Gut-First Parkinson's Disease: A Hypothesis
Per Borghammer et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP+-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons
Ichiro Kawahata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
David P. Breen et al.
MOVEMENT DISORDERS (2019)
Extracellular α-synuclein levels are regulated by neuronal activity
Kaoru Yamada et al.
MOLECULAR NEURODEGENERATION (2018)
Import and Export of Misfoldeda alpha-Synuclein
Lilia Rodriguez et al.
FRONTIERS IN NEUROSCIENCE (2018)
Alpha-Synuclein Modulates the Physical Properties of DNA
Kai Jiang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease
David I. Finkelstein et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Xiaobo Mao et al.
SCIENCE (2016)
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
α-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses
Naoto Sugeno et al.
SCIENTIFIC REPORTS (2016)
A small-angle X-ray scattering study of alpha-synuclein from human red blood cells
Katsuya Araki et al.
SCIENTIFIC REPORTS (2016)
Dopamine or biopterin deficiency potentiates phosphorylation at 40Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system
Ichiro Kawahata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
α-Synuclein interactions with phospholipid model membranes: Key roles for electrostatic interactions and lipid-bilayer structure
Katja Pirc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
α-synuclein assemblies sequester neuronal α3-Na+/K+-ATPase and impair Na+ gradient
Amulya Nidhi Shrivastava et al.
EMBO JOURNAL (2015)
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference
Ryotaro Ishii et al.
PLOS ONE (2015)
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease
David Hilton et al.
ACTA NEUROPATHOLOGICA (2014)
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology
Kathrin Doppler et al.
ACTA NEUROPATHOLOGICA (2014)
Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction
Jie Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
In Vitro Phosphorylation Does not Influence the Aggregation Kinetics of WT α-Synuclein in Contrast to Its Phosphorylation Mutants
Sarah Schreurs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Skin nerve α-synuclein deposits A biomarker for idiopathic Parkinson disease
Vincenzo Donadio et al.
NEUROLOGY (2014)
IN VIVO MODULATION OF POLO-LIKE KINASES SUPPORTS A KEY ROLE FOR PLK2 IN SER129 α-SYNUCLEIN PHOSPHORYLATION IN MOUSE BRAIN
M. Bergeron et al.
NEUROSCIENCE (2014)
Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
Georg Sebastian Nuebling et al.
PLOS ONE (2014)
Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
Ruth Chia et al.
NATURE COMMUNICATIONS (2014)
Protein phosphorylation in neurodegeneration: friend or foe?
Sandra Tenreiro et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors
Simeon Bowers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
Selective and Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors That Reduce -Synuclein Phosphorylation in Rat Brain
Danielle L. Aubele et al.
CHEMMEDCHEM (2013)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2013)
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
Patricia Silva Guerreiro et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
Kai-Yin Chau et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
Changyoun Kim et al.
NATURE COMMUNICATIONS (2013)
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
Penelope G. Foulds et al.
SCIENTIFIC REPORTS (2013)
Suppression of -synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
Vicente Sancenon et al.
HUMAN MOLECULAR GENETICS (2012)
Phosphorylation of α-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans
Tomoki Kuwahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease
Helene Pouclet et al.
MOVEMENT DISORDERS (2012)
α-SYNUCLEIN PHOSPHORYLATION AND TRUNCATION ARE NORMAL EVENTS IN THE ADULT HUMAN BRAIN
G. Muntane et al.
NEUROSCIENCE (2012)
Phosphorylation of alpha-synuclein upregulates tyrosine hydroxylase activity in MN9D cells
Bo Wu et al.
ACTA HISTOCHEMICA (2011)
Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease
Jinxia Zhou et al.
ACTA NEUROPATHOLOGICA (2011)
From Plk1 to Plk5 Functional evolution of Polo-like kinases
Guillermo de Carcer et al.
CELL CYCLE (2011)
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
Transmission of Prion Strains in a Transgenic Mouse Model Overexpressing Human A53T Mutated α-Synuclein
Anne-Laure J. Mougenot et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Characterization of Kinases Involved in the Phosphorylation of Aggregated α-Synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of α-Synuclein
Takafumi Hasegawa et al.
PLOS ONE (2011)
Contribution of Alanine-76 and Serine Phosphorylation in alpha-Synuclein Membrane Association and Aggregation in Yeasts
Michael Fiske et al.
PARKINSONS DISEASE (2011)
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Martial K. Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo
Haiyan Lou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
Lani K. Clinton et al.
JOURNAL OF NEUROSCIENCE (2010)
Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
Raquel Duran et al.
MOVEMENT DISORDERS (2010)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Lrrk2 interaction with α-synuclein in diffuse Lewy body disease
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease
Samareh Azeredo da Silveira et al.
HUMAN MOLECULAR GENETICS (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
Christine L. Kragh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells
Ichiro Kawahata et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Biological fluid biomarkers in neurodegenerative parkinsonism
Michael Eller et al.
NATURE REVIEWS NEUROLOGY (2009)
Modulation of α-Synuclein Aggregation by Dopamine: A Review
Su Ling Leong et al.
NEUROCHEMICAL RESEARCH (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein
Katerina E. Paleologou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Characterization of conformational and dynamic properties of natively unfolded human and mouse α-synuclein ensembles by NMR:: Implication for aggregation
Kuen-Phon Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Localization of CKII β subunits in Lewy bodies of Parkinson's disease
Myung Yi Ryu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease
Oleg S. Gorbatyuk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Paramagnetism-based NMR restraints provide maximum allowed probabilities for the different conformations of partially independent protein domains
Ivano Bertini et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α-synuclein:: Implication for α-synucleinopathies
Aasami Ishii et al.
FEBS LETTERS (2007)
Interactions between metals and α-synuclein -: function or artefact?
David R. Brown
FEBS JOURNAL (2007)
Oxidative stress-induced phosphorylation, degradation and aggregation of α-synuclein are linked to upregulated CK2 and cathepsin D
Makio Takahashi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families
Etsuro Ohta et al.
NEUROSCIENCE LETTERS (2007)
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Qiao-Xin Li et al.
EXPERIMENTAL NEUROLOGY (2007)
Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice
Christian Freichel et al.
NEUROBIOLOGY OF AGING (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease
Shigeki Arawaka et al.
JOURNAL OF NEUROSCIENCE (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
WW Smith et al.
HUMAN MOLECULAR GENETICS (2005)
Structure and properties of α-synuclein and other amyloids determined at the amino acid level
C Del Mar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
M Funayama et al.
ANNALS OF NEUROLOGY (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Overexpression of α-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of α-synuclein and activation of caspase-9:: resemblance to pathogenetic changes in Parkinson's disease
M Yamada et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
Initiation and synergistic fibrillization of tau and alpha-synuclein
BI Giasson et al.
SCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic Drosophila
M Takahashi et al.
NEUROSCIENCE LETTERS (2003)
Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions
M Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes
PJ Kahle et al.
EMBO REPORTS (2002)
A role for α-synuclein in the regulation of dopamine biosynthesis
RG Perez et al.
JOURNAL OF NEUROSCIENCE (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Alpha-synuclein and neurodegenerative diseases
M Goedert
NATURE REVIEWS NEUROSCIENCE (2001)
Conformational properties of α-synuclein in its free and lipid-associated states
D Eliezer et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Constitutive phosphorylation of the Parkinson's disease associated α-synuclein
M Okochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
